Back to Search
Start Over
Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome.
- Source :
-
Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2023 May 01; Vol. 45 (4), pp. e543-e546. Date of Electronic Publication: 2022 Oct 20. - Publication Year :
- 2023
-
Abstract
- Diencephalic syndrome is usually associated with tumors in the hypothalamic region, rarely occurring in patients with neurofibromatosis type 1 (NF1)-associated gliomas. We describe the clinical presentation and response to treatment in 3 patients with NF1 presenting with diencephalic syndrome as first symptom of optic pathway/hypothalamic glioma (OPHG). Because of the rarity of this constellation, knowledge about the clinical course and best treatment options for patients with NF1-associated OPHG and diencephalic syndrome is still limited. All 3 patients showed good response to treatment with normalization of body mass index and decrease in tumor volume within 6 months.<br />Competing Interests: The authors declare no conflict of interest.<br /> (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc.)
Details
- Language :
- English
- ISSN :
- 1536-3678
- Volume :
- 45
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of pediatric hematology/oncology
- Publication Type :
- Academic Journal
- Accession number :
- 36730977
- Full Text :
- https://doi.org/10.1097/MPH.0000000000002569